Johanna Friedl-Naderer
Chief Commercial OfficerMs. Johanna Friedl-Naderer serves as Chief Commercial Officer of Dyne Therapeutics, Inc. since September 03, 2024. She was Chief Operating Officer at Vir Biotechnology, Inc. since April 04, 2022 until September 29, 2023 and had been its Executive Vice President since March 02, 2022 until September 29, 2023. Ms. Friedl-Naderer served as Chief Business Officer of Global at Vir Biotechnology, Inc. since March 02, 2022 until April 04, 2022. As Chief Operating Officer, Ms. Friedl-Naderer is responsible for business development, finance, product development/regulatory and corporate affairs. She served as President of Europe, Canada and Partner Markets at Biogen Inc. since 2020 and where she served on the Global Extended Leadership Team since 2014. She has experience in the pharmaceutical industry. Having joined Biogen in 2001, she has served across a wide range of functions including Sales & Marketing, national and international General Management, Alliance Management and Corporate Development in both primary and specialty care and building and leading teams in advancing access to groundbreaking medicines for the treatment of devastating neurological conditions, including multiple sclerosis, spinal muscular atrophy, amyotrophic lateral sclerosis and Alzheimers disease. She has also served on several boards, including the European Federation of Pharmaceutical Industries & Associations (EFPIA), the Swiss-American Chamber of Commerce, Interpharma and the council of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
Positions
- Company NameDyne Therapeutics, Inc.Stock CodeDYNPositionChief Commercial OfficerColleagues
- JGJohn G. CoxCEO, President & Director
- JPJason P. RhodesIndependent Chairman
- EJErick J. LuceraCFO, Principal Financial Officer & Principal Accounting Officer and Treasurer
- OBOxana BeskrovnayaChief Innovation Officer
- DKDouglas KerrHead of Research & Development and Chief Medical Officer
- DKDirk KerstenIndependent Director
- DCDavid Charles LubnerIndependent Director
- EMEdward M. HurwitzIndependent Director
